<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02018835</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01093-40</org_study_id>
    <secondary_id>2012-28</secondary_id>
    <nct_id>NCT02018835</nct_id>
  </id_info>
  <brief_title>Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.</brief_title>
  <official_title>Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Detecting abnormalities in the left ventricular mechanical and hemodynamic response to the&#xD;
      stress of exercise may offer early diagnostic indicators in patients suffering from valvular&#xD;
      disease such as mitral regurgitation. Ultrasound-based imaging methods have been gaining&#xD;
      importance in providing prognosis among those patients. However, decreased signal to noise&#xD;
      ratio in the images and increased motion-related artifacts during exercise stress&#xD;
      echocardiography have been reported, with a lack of reproducibility of results and a the&#xD;
      limitation of its availability only in reference centers. In our laboratory, we are able to&#xD;
      perform supine bicycle exercise MRI (1.5 T) using the Lode ergometer mounted on the far end&#xD;
      of the patient table, previously described in healthy volunteers.&#xD;
&#xD;
      The first aim of our study is to demonstrate the safety and the feasibility of our MRI&#xD;
      protocol in selected patients with asymptomatic severe organic mitral regurgitation, to&#xD;
      assess left ventricular volumes and function, and regurgitant volume in comparison to&#xD;
      exercise cardiac echography.&#xD;
&#xD;
      Besides, few recent studies sustain the relevance of novel markers of central aortic function&#xD;
      (compliance, distensibility and pulse wave velocity) assessed by noninvasive MRI to explore&#xD;
      vascular aging. In monogenic connective tissue diseases, altered arterial stiffness is the&#xD;
      premature signature of the disease in asymptomatic patients. Noninvasive evaluation of aortic&#xD;
      stiffness would be useful for risk assessment and preventive follow-up strategies in young&#xD;
      asymptomatic relatives of subjects with aortic inherited diseases, such as syndromic and&#xD;
      non-syndromic familial forms of thoracic aortic aneurysm and /or dissection. Furthermore,&#xD;
      this technique should be able to evaluate the effect of drugs on aortic stiffness change in&#xD;
      trials, before and after drug therapy, more relevant than the classic change in aortic&#xD;
      diameter measurement.&#xD;
&#xD;
      The second aim of our study is 1) to provide the sensibility of our MRI protocol to estimate&#xD;
      local and regional heterogeneity in aortic functional parameters (distensibility, compliance&#xD;
      and PWV) 2) to evaluate the predictive value of these regional aortic parameters assessed by&#xD;
      MRI to diagnose and to stratify the aortopathy related to presymptomatic Marfan patients and&#xD;
      to bicuspid aortic valve in young adults, in comparison to carotids-femoral pulse wave&#xD;
      velocity estimation by applanation tonometry.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood samples</measure>
    <time_frame>24 MONTHS</time_frame>
    <description>to estimate local and regional heterogeneity in aortic functional parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>aortic function</measure>
    <time_frame>24 MONTHS</time_frame>
    <description>MRI - magnetic resonance imaging</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Dilated Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>patients of an insufficiency organic severe surgical mitrale</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>insufficiency organic mitrale moderated in severe asymptomatic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients of an aortic bicuspidie</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients of a syndrome of Marfan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>insufficiency organic mitrale moderated in severe asymptomatic</arm_group_label>
    <arm_group_label>patients of a syndrome of Marfan</arm_group_label>
    <arm_group_label>patients of an aortic bicuspidie</arm_group_label>
    <arm_group_label>patients of an insufficiency organic severe surgical mitrale</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cardiac echography transthoracic</intervention_name>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>insufficiency organic mitrale moderated in severe asymptomatic</arm_group_label>
    <arm_group_label>patients of a syndrome of Marfan</arm_group_label>
    <arm_group_label>patients of an aortic bicuspidie</arm_group_label>
    <arm_group_label>patients of an insufficiency organic severe surgical mitrale</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Autonomous ADULT patient,&#xD;
&#xD;
        patient Marfan:&#xD;
&#xD;
          -  under their usual treatment(processing) (including ÃŸ blocking)&#xD;
&#xD;
          -  diagnosis confirmed by the molecular biology (transfer(transformation) of the gene&#xD;
             FBN1)&#xD;
&#xD;
          -  Asymptomatic or Dilation of the aorta = 40 mm on the ascending aorta on an&#xD;
             echocardiography or an imaging in cups(cuttings) dating less than 6 months.&#xD;
&#xD;
        PATIENT Aortic bicuspid :&#xD;
&#xD;
          -  Diagnosis confirmed by cardiac echography and/or imaging in cups(cuttings)&#xD;
&#xD;
          -  Asymptomatic or Dilation of the aorta = 40 mm on the ascending aorta, and absence of&#xD;
             valvulopathy aortic significant (IA of rank I in II, absence of significant RA), on&#xD;
             the echocardiography or the imaging in cups(cuttings) dating less than 6 months.&#xD;
&#xD;
        patients Insufficiency mitral organic moderated in severe asymptomatic:&#xD;
&#xD;
          -  SOR &gt; 30 mm2, on an echocardiography or an imaging in cups(cuttings) dating less than&#xD;
             6 months&#xD;
&#xD;
          -  Absence of ischemic or functional cause&#xD;
&#xD;
          -  Patient recovering from a functional evaluation by echography of effort&#xD;
&#xD;
        patients Insufficiency mitral organic severe surgical&#xD;
&#xD;
          -  SOR &gt; 40 mm2, on an echocardiography or an imaging in cups(cuttings) dating less than&#xD;
             6 months&#xD;
&#xD;
          -  Absence of ischemic or functional cause&#xD;
&#xD;
          -  Status functional: stage(stadium) II of the NYHA&#xD;
&#xD;
          -  Patient recovering from a functional evaluation by echography of effort&#xD;
&#xD;
        Volunteer healthy :&#xD;
&#xD;
          -  affiliated to the Social Security&#xD;
&#xD;
          -  having given its agreement by signed consent&#xD;
&#xD;
          -  not presenting contraindication to the realization of a MRI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient claustrophobic,&#xD;
&#xD;
          -  patient refusing the protocol or the examination&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD BELAIGUES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>alexis jacquier</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP HM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jacquier alexis</last_name>
    <phone>0491388457</phone>
    <email>alexis.jacquier@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>bernard belaigues</last_name>
      <phone>0491382747</phone>
      <email>dir.recherche@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>alexis jacquier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>November 26, 2012</study_first_submitted>
  <study_first_submitted_qc>December 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2013</study_first_posted>
  <last_update_submitted>August 6, 2015</last_update_submitted>
  <last_update_submitted_qc>August 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

